Possible mechanisms of endoreduplication induction. Membrane fixation and/or disruption of the cytoskeleton.
D015112:4-Nitroquinoline-1-oxide / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D002455:Cell Division; D002460:Cell Line; D002875:Chromosomes / Q000187:drug effects*; D006224:Cricetinae; D000242:Cyclic AMP / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D003553:Cystine / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D037102:Lectins / Q000037:antagonists & inhibitors; D008168:Lung; D008297:Male; D008938:Mitosis; D009943:Organophosphorus Compounds / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology; D014753:Vinyl Compounds / Q000494:pharmacology
D037102:Lectins; D009943:Organophosphorus Compounds; D014753:Vinyl Compounds; D003561:Cytarabine; D003609:Dactinomycin; D003553:Cystine; D011691:Puromycin; D015112:4-Nitroquinoline-1-oxide; D000242:Cyclic AMP; D014357:Trypsin; D003545:Cysteine